论文部分内容阅读
尿激酶(Urohinase,简称UK)是一种新发展的溶血栓药物。其作用机理是先激活体内纤溶酶元(Plasminogen)成为有活性的纤维酶(Plasmin),后者能将纤维蛋白水解。UK没有抗原性,没有毒性及其他副反应,临床用于治疗各种血栓形成和血栓栓塞性疾病以及因纤维蛋白沉着引起
Urokinase (UK) is a newly developed thrombolytic drug. Its mechanism of action is to activate plasminogen in vivo to become an active Plasmin, which hydrolyzes fibrin. UK has no antigenicity, no toxicity and other side effects, is clinically used to treat various thrombotic and thromboembolic diseases and due to fibrin deposition